LEADER 03222nam 22006132 450 001 9910777760503321 005 20160512105003.0 010 $a1-107-19285-4 010 $a0-511-51773-4 010 $a0-511-51511-1 010 $a0-511-51419-0 010 $a0-511-57552-1 010 $a0-511-51639-8 035 $a(CKB)1000000000748430 035 $a(EBL)431984 035 $a(OCoLC)609832748 035 $a(SSID)ssj0000113427 035 $a(PQKBManifestationID)11140386 035 $a(PQKBTitleCode)TC0000113427 035 $a(PQKBWorkID)10099258 035 $a(PQKB)10778432 035 $a(UkCbUP)CR9780511575525 035 $a(MiAaPQ)EBC431984 035 $a(Au-PeEL)EBL431984 035 $a(CaPaEBR)ebr10297129 035 $a(PPN)261354302 035 $a(EXLCZ)991000000000748430 100 $a20141103d2009|||| uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe BMT data book /$fReinhold Munker, Hillard M. Lazarus, Kerry Atkinson$b[electronic resource] 205 $a2nd edition. 210 1$aCambridge :$cCambridge University Press,$d2009. 215 $a1 online resource (xvi, 526 pages) $cdigital, PDF file(s) 300 $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015). 311 $a0-521-71100-2 320 $aIncludes bibliographical references and index. 327 $aCover; Half-title; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Section 1 Basic science; Section 2 Hematologic malignancies; Section 3 Solid tumors; Section 4 Nonmalignant disorders; Section 5 Practical aspects and procedures; Section 6 Complications; Section 7 The BMT/SCT pharmacopoeia; Section 8 HLA-testing and laboratorymedicine; Appendix; Index 330 $aThe BMT Data Book is an essential guide to the data, outcome studies and complex decision-making processes involved in blood and marrow stem cell transplantation. Organized according to types of diseases and procedures, it contains more than hundred tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between stem cell versus bone marrow transplantation, autologous versus allogeneic transplantation, and conventional versus experimental treatments. This new edition summarizes research of the last 5 years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndromes, Hodgkin's and Non-Hodgkin's lymphomas. In addition, controversies and new indications - like renal cell cancer and autoimmune disorders - are discussed plus new drugs and therapies, new stem cell sources (cord blood), new transplant protocols (reduced-intensity conditioning), and a guide to electronic databases. 606 $aBone marrow$xTransplantation 615 0$aBone marrow$xTransplantation. 676 $a617.4/40592 700 $aAtkinson$b Kerry$01577005 702 $aMunker$b Reinhold 702 $aLazarus$b Hillard M. 801 0$bUkCbUP 801 1$bUkCbUP 906 $aBOOK 912 $a9910777760503321 996 $aThe BMT data book$93855215 997 $aUNINA